Skip to main content

Table 3 Clinical features and laboratory results of the 38 IM patients

From: Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients

Num Clinical type HA test EBV-VCA IgM RT-PCR (copies/ml) FISH positivity (per 100 cells) FISH fluorescent
particles outcome
1 mild - 1:10 3.65×103 61.5% 8.52/+ alive
2 mild + - 7.05×103 3.0% 0.62/- alive
3 mild + 1:20 6.26×105 66.0% 11.42/+ alive
4 mild - 1:160 6.21×103 54.5% 13.06/+ alive
5 mild + 1:320 4.75×105 56.5% 13.78/+ alive
6 mild - - 2.02×104 62.0% 29.91/+ alive
7 mild + - 4.35×104 42.5% 7.78/+ alive
8 mild + 1:640 9.05×104 65.0% 10.75/+ alive
9 mild - 1:160 7.32×105 57.5% 11.35/+ alive
10 mild + 1:160 3.45×103 72.5% 14.52/+ alive
11 mild + 1:80 5.09×105 63.0% 7.89/+ alive
12 mild - 1:160 7.32×103 56.5% 9.24/+ alive
13 mild + - 3.26×103 70.5% 6.28/+ alive
14 mild - 1:80 8.25×105 50.5% 10.79/+ alive
15 mild + - 6.32×103 63.0% 11.24/+ alive
16 mild - - 9.37×105 41.5% 13.52/+ alive
17 mild + 1:160 8.02×105 67.5% 14.36/+ alive
18 mild + 1:80 7.22×103 70.5% 9.01/+ alive
19 mild + - 6.91×104 52.0% 19.43/+ alive
20 mild - 1:20 6.44×103 45.5% 11.21/+ alive
21 mild + 1:80 4.28×105 35.5% 12.36/+ alive
22 mild + 1:20 1.75×104 45.5% 13.42/+ alive
23 mild - - 3.92×105 72.5% 14.53/+ alive
24 mild + 1:320 1.07×104 65.5% 14.76/+ alive
25 mild - 1:20 <500 42.0% 13.23/+ alive
26 mild + 1:20 <500 53.0% 9.17/+ alive
27 mild + 1:80 3.05×103 67.0% 8.79/+ alive
28 mild + - 3.59×105 71.0% 6.42/+ alive
29 mild - 1:40 <500 39.0% 5.75 /+ alive
30 mild - 1:20 <500 25.0% 12.31/+ alive
31 mild - 1:320 2.63×104 51.5% 14.53/+ alive
32 severe/EBV-HLH + 1:160 3.75×103 97.5% 32.82/+ alive
33 severe/EBV-HLH - 1:320 4.5×107 100% 36.66/+ deceased
34 severe/EBV-HLH + 1:640 3.05×104 89.5% 39.08/+ deceased
35 severe/EBV-HLH + - 5.05×104 91.0% 51.03/+ alive
36 severe/CAEBV + 1:40 8.92×106 83.5% 53.44/+ alive
37 severe/CAEBV - 1:320 8.26×107 100% 55.34/+ deceased
38 severe/CAEBV + 1:80 4.75×105 87.5% 48.28/+ alive